Khan et al. reported that knocking down Slc27a2 reduced the abnormally elevated blood glucose concentration in model mice (Khan et al., 2020), indicating that FATP2 could regulate blood glucose homeostasis and the progression of diabetic nephropathy. Here, SLC27A2 is linked to diabetic kidney disease.